1.
Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis. J of Skin [Internet]. 2018 Dec. 17 [cited 2025 Apr. 18];2:S63. Available from: https://skin.dermsquared.com/skin/article/view/459